FR2354768B1 - - Google Patents

Info

Publication number
FR2354768B1
FR2354768B1 FR7718680A FR7718680A FR2354768B1 FR 2354768 B1 FR2354768 B1 FR 2354768B1 FR 7718680 A FR7718680 A FR 7718680A FR 7718680 A FR7718680 A FR 7718680A FR 2354768 B1 FR2354768 B1 FR 2354768B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7718680A
Other languages
French (fr)
Other versions
FR2354768A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of FR2354768A1 publication Critical patent/FR2354768A1/fr
Application granted granted Critical
Publication of FR2354768B1 publication Critical patent/FR2354768B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR7718680A 1976-06-18 1977-06-17 Composition antibacterienne Granted FR2354768A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51072458A JPS6049602B2 (ja) 1976-06-18 1976-06-18 抗菌剤

Publications (2)

Publication Number Publication Date
FR2354768A1 FR2354768A1 (fr) 1978-01-13
FR2354768B1 true FR2354768B1 (US20030199744A1-20031023-C00003.png) 1981-01-09

Family

ID=13489871

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7718680A Granted FR2354768A1 (fr) 1976-06-18 1977-06-17 Composition antibacterienne

Country Status (8)

Country Link
US (1) US4092411A (US20030199744A1-20031023-C00003.png)
JP (1) JPS6049602B2 (US20030199744A1-20031023-C00003.png)
AU (1) AU512893B2 (US20030199744A1-20031023-C00003.png)
BE (1) BE855766A (US20030199744A1-20031023-C00003.png)
DE (1) DE2727247A1 (US20030199744A1-20031023-C00003.png)
FR (1) FR2354768A1 (US20030199744A1-20031023-C00003.png)
GB (1) GB1524180A (US20030199744A1-20031023-C00003.png)
NL (1) NL7706461A (US20030199744A1-20031023-C00003.png)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196193A (en) * 1978-02-15 1980-04-01 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition
US20050009931A1 (en) * 2003-03-20 2005-01-13 Britten Nancy Jean Dispersible pharmaceutical composition for treatment of mastitis and otic disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923977A (en) * 1972-08-29 1975-12-02 Fujisawa Pharmaceutical Co Antibiotic FR-1923 substance

Also Published As

Publication number Publication date
AU2620677A (en) 1978-12-21
US4092411A (en) 1978-05-30
DE2727247A1 (de) 1977-12-29
AU512893B2 (en) 1980-11-06
JPS6049602B2 (ja) 1985-11-02
BE855766A (fr) 1977-12-16
GB1524180A (en) 1978-09-06
NL7706461A (nl) 1977-12-20
JPS52156931A (en) 1977-12-27
FR2354768A1 (fr) 1978-01-13

Similar Documents

Publication Publication Date Title
FR2351441B3 (US20030199744A1-20031023-C00003.png)
FR2356348B1 (US20030199744A1-20031023-C00003.png)
CH629925GA3 (US20030199744A1-20031023-C00003.png)
FR2354768B1 (US20030199744A1-20031023-C00003.png)
JPS554173Y2 (US20030199744A1-20031023-C00003.png)
JPS5616339B2 (US20030199744A1-20031023-C00003.png)
JPS5348503U (US20030199744A1-20031023-C00003.png)
JPS52136414U (US20030199744A1-20031023-C00003.png)
JPS552794B2 (US20030199744A1-20031023-C00003.png)
JPS5394734U (US20030199744A1-20031023-C00003.png)
CS178388B1 (US20030199744A1-20031023-C00003.png)
JPS53121324U (US20030199744A1-20031023-C00003.png)
JPS52169259U (US20030199744A1-20031023-C00003.png)
JPS536508U (US20030199744A1-20031023-C00003.png)
JPS52141387U (US20030199744A1-20031023-C00003.png)
JPS5362341U (US20030199744A1-20031023-C00003.png)
JPS52117203U (US20030199744A1-20031023-C00003.png)
JPS5365661U (US20030199744A1-20031023-C00003.png)
JPS5374272U (US20030199744A1-20031023-C00003.png)
CS177793B1 (US20030199744A1-20031023-C00003.png)
CS178350B1 (US20030199744A1-20031023-C00003.png)
DD126489A1 (US20030199744A1-20031023-C00003.png)
DD123561A1 (US20030199744A1-20031023-C00003.png)
DD126549A1 (US20030199744A1-20031023-C00003.png)
CH598497A5 (US20030199744A1-20031023-C00003.png)

Legal Events

Date Code Title Description
ST Notification of lapse